N‐ glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer
Advanced Science · 2025-02 · 12 (7)
DOI: 10.1002/advs.202411740 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.12.2024. Verfasst von Nan Xiong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, 100044, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Cathepsin D. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Beijing Xisike Clinical Oncology Research Foundation.
Abstract (Originalsprache)
Liver metastasis is the primary factor contributing to unfavorable prognosis in colorectal cancer (CRC). Although N ‐glycosylation is implicated in metastasis, there is a notable paucity of comprehensive studies addressing the N ‐glycosylation proteomics associated with liver metastasis in CRC. In this study, N‐ glycosylated proteins and N‐ glycosylation sites of differential expression between primary lesions and paired liver metastatic lesions are identified. Cathepsin D (CTSD) is further screened as a potentially pivotal N‐ glycosylated protein in CRC liver metastasis. Glycosyltransferases complex DDOST and STT3B can regulate N‐ glycosylation modification at residue 263 of CTSD (a protease), thereby affecting CTSD protease to lyse ACADM. ACADM can regulate ferroptosis‐related proteins (ACSL4, SLC7A11, and GPX4) to further influence the invasion and metastasis of CRC cells. This newly discovered mechanism provides potential therapeutic targets for CRC treatment and insights for controlling CRC progression and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, 100044, China.
- Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, 100044, China.
- Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, 100044, China.
- Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing, 100101, China.
- University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 100049, China.
- Western Institute of Health Data Science, 28 High Tech Avenue, Chongqing, 401329, China.
ORCID-Profile: Zhanlong Shen
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Beijing Xisike Clinical Oncology Research Foundation
- Beijing Bethune Charitable Foundation
- National Key Research and Development of China
- National Natural Science Foundation of Chongqing
- the project of "Dengfeng plan" from Foshan Hospital of Traditional Chinese Medicine
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Xiong, N., Du, Y., Huang, C., Yan, Q., Zhao, L., Yang, C., Sun, Q., Gao, Z., Wang, C., Zhan, J., Zhang, H., Wang, S., Ye, Y., Li, Y., & Shen, Z. (2025). N‐ glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer. Advanced Science, 12(7). https://doi.org/10.1002/advs.202411740
Vancouver
Xiong N, Du Y, Huang C, Yan Q, Zhao L, Yang C, et al. N‐ glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer. Advanced Science. 2025;12(7). doi:10.1002/advs.202411740
BibTeX
@article{Xiong2025,
author = {Xiong, Nan and Du, Yan and Huang, Chuncui and Yan, Quanyi and Zhao, Long and Yang, Changjiang and Sun, Qing and Gao, Zhidong and Wang, Caihong and Zhan, Jun and Zhang, Hongquan and Wang, Shan and Ye, Yingjiang and Li, Yan and Shen, Zhanlong},
title = {N‐ glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {7},
doi = {10.1002/advs.202411740}
}
EUVIMED